Pavithra M S, Vijendra R, Suja Xaviar
Pavithra M S1, Vijendra R2, Suja Xaviar3*
1Department of Pharmacology, Kempegowda Institute of Medical Sciences and Research Centre, Bengaluru – 560070.
2Department of Pharmacology, Kempegowda Institute of Medical Sciences and Research Centre, Bengaluru – 560070.
3Department of Pharmacology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry – 605006.
Volume - 15,
Issue - 6,
Year - 2022
Background: Spontaneous reporting of adverse drug reactions (ADRs) is one of the most common methods to obtain safety data. Lack of awareness is a major reason for under reporting. Hence, this study was undertaken to evaluate the knowledge, attitude and practices (KAP) of the postgraduates about pharmacovigilance and ADR reporting in Kempegowda Institute of Medical Sciences (KIMS), Bengaluru, a tertiary care teaching hospital.
Materials and Methods: A cross-sectional questionnaire-based survey was conducted among postgraduate students in a tertiary care teaching hospital in South India to evaluate the participants’ knowledge, attitude, and practice (KAP) on ADRs and Pharmacovigilance. A pre-designed and validated question¬naire containing 14 questions was used to assess knowledge, attitude and practice. The filled KAP questionnaires were analyzed and their percentage value was calculated by using Microsoft Excel spreadsheet. Results: A total of 120 postgraduate students participated in the study. Around 81% of participants agreed that reporting of ADRs is a professional obligation and all ADRs should be reported. They did not have adequate knowledge regarding the purpose of monitoring ADRs and 22.5% of study participants were unclear as to where and how to report ADRs. Unfortunately, only 12.5% of participants actually reported ADRs due to lack of proper sensitization and knowledge of pharmacovigilance and ADR. Conclusion: This study revealed that the postgraduate students have a good attitude towards ADR reporting. However, they lack knowledge and the actual practice of ADR reporting is still lacking among them. There is a need to create awareness among the health care professionals about ADR reporting and pharmacovigilance. Educational interventions targeting the medical fraternity should be implemented to help improve spontaneous reporting and knowledge of pharmacovigilance and ADR.
Cite this article:
Pavithra M S, Vijendra R, Suja Xaviar. A Questionnaire based Cross-sectional Study to assess Knowledge, Attitude and Practice of Pharmacovigilance and Adverse Drug Reaction Reporting among Postgraduate Medical students in a Tertiary Care Teaching Hospital of South India. Research Journal of Pharmacy and Technology. 2022; 15(6):2391-4. doi: 10.52711/0974-360X.2022.00397
Pavithra M S, Vijendra R, Suja Xaviar. A Questionnaire based Cross-sectional Study to assess Knowledge, Attitude and Practice of Pharmacovigilance and Adverse Drug Reaction Reporting among Postgraduate Medical students in a Tertiary Care Teaching Hospital of South India. Research Journal of Pharmacy and Technology. 2022; 15(6):2391-4. doi: 10.52711/0974-360X.2022.00397 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2022-15-6-1
1. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: A meta‑analysis of prospective studies. JAMA 1998; 279:1200‑5.
2. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, et al. Adverse drug reactions as cause of admission to hospital: Prospective analysis of 18 820 patients. BMJ 2004; 329:15‑9.
3. Oshikoya KA. Adverse drug reaction in children: Types, incidence and risk factors. Niger J Paediatr2006; 33:29‑35.
4. Martínez‑Mir I, García‑López M, Palop V, Ferrer JM, Rubio E, Morales‑Olivas FJ. A prospective study of adverse drug reactions in hospitalized children. Br J Clin Pharmacol 1999; 47:681‑8.
5. Oshikoya KA, Awobusuyi JO. Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in Lagos, Nigeria. BMC Clin Pharmacol 2009 11; 9:14.
6. Ahmad SR. Adverse drug event monitoring at the Food and Drug Administration. J Gen Intern Med 2003; 18:57‑60.
7. Abdullahi Rabiu Abubakar, Nordin Bin Simbak, Mainul Haque. Adverse Drug Reactions: Predisposing Factors, Modern Classifications and Causality Assessment. Research J. Pharm. and Tech. 7(9): Sept. 2014 Page 1091-1098.
8. Rayees N M, Sampath Kumar, Bharath Raj K C, Rajesh K S, Juno J Joel, Prasanna Shama K, Gururaja M P, Nandakumar U P. A Prospective Observational Study on Adverse Drug Reactions in General Medicine Department of a Tertiary Care Teaching Hospital. Research J. Pharm. and Tech. 2019; 12(5):2289-2298. doi: 10.5958/0974-360X.2019.00382.2
9. Priyanka Paruthi, Ganesh Pansare, Avinash Khairnar. Use of Triggers to Detect Adverse Drug Reaction Induced By Cardiovascular Drugs in Outpatient Department in Nasik City. Research J. Pharm. and Tech. 4(12): Dec. 2011; Page 1819-1821.
10. Meyboom R, Osslen S, Thorogood M. Teaching pharmacovigilance. In: Mann RD, Andrews EB, editor. Pharmacovigilance. Chichester: John Wiley and Sons; 2002. p. 505‑8.
11. Pharmacovigilance programme of India 2010. CDSCO, Ministry of Health and Family Welfare, Government of India. 2010. Available from: http://www.cdsco.nic.in/pharmacovigilance.html. [Last accessed on 2020 March 31].
12. Hailye Birhane, Mojahidul Islam, Damen H/mariam, Vijender Singh. Pharmacovigilance: Adverse Drug Reactions (ADRs) in Pediatric patients in Ethiopia. Retrospective Study. Research J. Pharm. and Tech 2021; 14(3):1499-1506. doi: 10.5958/0974-360X.2021.00266.3
13. Hartigan‑Go K. Pharmacovigilance and the pursuit of rational drug use: The Philippines experience. Uppsala Rep 2001; 14S: 1‑4.
14. Badar Uddin Umar, Mainul Haque. Adverse Drug Reactions in Bangladeshi Health Care Setup: An Update. Research J. Pharm. and Tech. 8(11): Nov., 2015; Page 1598-1602. doi: 10.5958/0974-360X.2015.00287.5
15. Sornalakshmi. K, Vadivu. G, Sujatha G, Hemavathi. D. A Survey on using Social Media Data Analytics for Pharmacovigilance. Research J. Pharm. and Tech 2017; 10(10):3474-3478. doi: 10.5958/0974-360X.2017.00621.7
16. Green CF, Mottram DR, Brown AM, Rowe PH. Attitudes of hospital pharmacists to adverse drug reactions and the ‘yellow card’ scheme: A qualitative study. Int J Pharm Pract 1999; 7:247‑55
17. Amrita P, Kharbanda B. Knowledge, attitude and skills of nurses of Delhi towards adverse drug reaction reporting. Indian J Pharm Pract 2012; 5:45‑51.
18. Geneva, Switzerland: Office of Publications; 2002. World Health Organization (WHO) (A) World Health Organization. The Importance on Pharmacovigilance. Safety Monitoring on Medicinal Products. WHO/EDM/QSM/2002.
19. Perlik F, Slanar O, Smíd M, Petracek J. Attitude of Czech physicians to adverse drug reaction reporting. European journal of clinical pharmacology. 2002 Aug 1; 58(5):367-9.
20. Hasford J, Goettler M, Munter KH, Müller-Oerlinghausen B. Physicians' knowledge and attitudes regarding the spontaneous reporting system for adverse drug reactions. Journal of clinical epidemiology. 2002 Sep 1; 55(9):945-50.
21. Palaian S, Ibrahim MI, Mishra P. Health professionals' knowledge, attitude and practices towards pharmacovigilance in Nepal. Pharm Pract (Granada) 2011; 9:228-35
22. Khan SA, Goyal C, Chandel N, Rafi M. Knowledge, attitudes, and practice of doctors to adverse drug reaction reporting in a teaching hospital in India: An observational study. J Nat Sci Biol Med. 2013; 4(1):191-6.
23. Arun Sharma, S Amarnath, S Jaikumar, S. Basalingappa, S. Ramaswamy, M. Thulasimani. Assessment of Knowledge about Pharmacovigilance among Medical Students in Puducherry. Research J. Pharm. and Tech. 7(4): April, 2014; Page 447-449.
24. Vora MB, Paliwal NP, Doshi VG, Barvaliya MJ, Tripathi CB. Knowledge of adverse drug reactions and pharmacovigilance activity among the undergraduate students of Gujarat. Int J Pharm Sci Res 2012; 3:1511-5
25. Anuradha CR, Komathi J, Subashree A. A cross-sectional study on the knowledge, attitude, and practices of pharmacovigilance among health-care professionals at a tertiary care teaching hospital. National Journal of Physiology, Pharmacy and Pharmacology. 2020;10(08):682-7.
26. Al Rabayah AA, Esra’a Mahmoud Hanoun RH, Rumman A. Assessing knowledge, attitude, and practices of health-care providers toward pharmacovigilance and adverse drug reaction reporting at a comprehensive cancer center in Jordan. Perspectives in clinical research. 2019 Jul; 10(3):115.
27. Radhakrishnan R, Vidyasagar S, Varma DM. An educational intervention to assess knowledge attitude practice of pharmacovigilance among health care professionals in an Indian Tertiary Care Teaching Hospital. Int J PharmTech Res 2011; 3:678-92. Back to cited text no. 21
28. Subish P, Mahamed Izam MI, Mishra P, Shankar PR, Alam K. Education session for pharmacy students on pharmacovigilance. A preliminary study. J Clin Diagn Res 2010; 4:2427-32.
29. Kumar S, Badruddeen, Singh S P, Juber A, Khan M I. Evaluation of dermatological adverse drug reactions in a tertiary care hospital of northern India. Research Jour Pharm and Tech. 2019; 12(7): 3517-3521.
30. Chinnu Scaria, Ananthu Satheesh, Pooja Prabhakar, Juno J. Joel, Shishir Kumar. Evaluation of Adverse Drug Reactions and their Management in Psychiatric in-Patients. Research J. Pharm. and Tech. 2019; 12(7):3455-3461. doi: 10.5958/0974-360X.2019.00585.7
31. S Lincy, M Greeshma, E Maheswari, S Tharanath, Subeesh Viswam. An Empirical Study to assess the Pattern and Predictors of Adverse Drug Reactions associated with Polypharmacy in the Department of General Medicine. Research J. Pharm. and Tech 2018; 11(11): 5042-5048. doi: 10.5958/0974-360X.2018.00919.8